Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Misty Shields

Thoracic Oncology · IUSM

View

Dr. Gilberto Lopes

Thoracic Oncology · University of Miami

View

Dr. Jacob Sands

Thoracic Oncology · Dana-Farber Cancer Institute

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    SRDr. Suresh Ramalingam

    Dr. Suresh Ramalingam

    Medical Oncology · Thoracic Oncology
    Emory University
    sureshr

    Research

    Cotargeting DNA topoisomerase II enhances efficacy of RAS-targeted therapy in KRAS-mutant cancer models

    2026

    Via J Clin Invest

    Research

    Selective depletion of virus-specific CD8 T cells from the liver after PD-1 therapy with Fc-intact antibody during chronic infection

    2026

    Via Proc Natl Acad Sci U S A

    Research

    Exposed phosphatidylserine is an inhibitory molecule in T cell exhaustion

    2026

    Via Nature

    Research

    Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer

    2026

    Via Curr Probl Cancer

    Research

    Inhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer

    2026

    Via EMBO Mol Med

    Research

    Early detection of invasive lung cancer and multiorgan metastasis by a collagen-targeted protein MRI contrast agent

    2026

    Via Sci Adv

    Research

    From ADAURA to LAURA: the evolving role of EGFR-targeted therapy in NSCLC

    2026

    Via Clin Adv Hematol Oncol

    Research

    Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data

    2026

    Via JTO Clin Res Rep

    Research

    Participation in lung cancer biospecimen studies: an analysis of the ECOG-ACRIN phase 3 E1505 and E5508 clinical trials

    2026

    Via Lung Cancer

    Research

    A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

    2026

    Via Future Oncol

    Research

    ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib

    2026

    Via Cancer Discov

    Research

    Patient-reported outcomes from the LAURA study: osimertinib in patients with unresectable stage III EGFR-mutated non-small cell lung cancer after definitive chemoradiotherapy

    2026

    Via Eur J Cancer

    Research

    "Protected time" for clinical investigators in medical oncology: The persistent gap between expectation and reality

    2026

    Via Cancer

    Research

    Closing the Gap in Lung Cancer Outcomes-Medicaid Expansion for Communities With the Most to Gain

    2026

    Via JAMA Netw Open

    Research

    Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms

    2026

    Via JCO Oncol Pract